Fast-dispersing dosage forms for the pediatric market

Drug Delivery Technology

Volumn 11, Issue 2, 2011, Pages 32-35

  Banbury, Susan ^a   MacGregor, Karen ^a  

^a CATALENT PHARMA SOLUTIONS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OLANZAPINE; ONDANSETRON;

BLISTER PACK; CHILD PSYCHIATRY; CRYOPRESERVATION; DEHYDRATION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG DOSAGE FORM; DRUG DOSE; DRUG MANUFACTURE; DRUG MARKETING; DRUG PACKAGING; DRUG PENETRATION; DRUG STABILITY; EMERGENCY WARD; FREEZE DRYING; GASTROENTERITIS; HUMAN; NAUSEA AND VOMITING; PALATABILITY; PEDIATRICS; SHORT SURVEY; SINGLE DRUG DOSE; TABLET; TABLET COMPRESSION; TABLET DISINTEGRATION;

EID: 79952336455     PISSN: 15372898     EISSN: 1944818X     Source Type: Trade Journal    
DOI: None     Document Type: Short Survey

References (7)

1. Pediatric Drug Delivery, Greystone Research Associates, December 15, 2009.
2. GBI Research's report. Oral Drug Delivery Market - Controlled and Sustained Release to be Major Revenue Generators. November 2010.
3. Technology Catalysts International report. Orally Disintegrating Tablet and Film Technologies. 6th Edition. September 2010.
4. Laxman Kate, Anuradha Pol, Vandana Patravale. Advantages of Oral Fast Dissolving Films. PharmaBiz.com. September 22, 2010.
5. Jaysukh JH, Rathod DA, Vadalia KR. Orally disintegrating tablets: a review. Topical J Pharmaceut Res. 2009 8(2):161-172.
6. EMEA, Committee for Medicinal Products for Human Use (CHMP), Reflection Paper: Formulations of Choice for the Paediatric Population, Adoption by CHMP Sept 21, 2006. www.ema.europa.eu/docs/en-GB/document-library/Scientific- guideline/2009/09/WC500003782.pdf. Website accessed January 31, 2011.
7. Freedman SB, Adler M, Seshadri R, Powell EC. Oral ondansetron for gastroenteritis in a pediatric emergency department. NEJM. 2006;354(16):1698- 1705.